Raday Gilead (CIK 2113137) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-13). Recent activity: Sell RDHL (14.1M shares), Sell RDHL (15.7M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-13 | RedHill Biopharma Ltd. (RDHL) | Chief Operating Officer | Sell | 14.1M | $1,413 |
| 2026-04-22 | RedHill Biopharma Ltd. (RDHL) | Chief Operating Officer | Sell | 15.7M | $1,574 |
Source: SEC Form 4 filings · as of 2026-07-13